Bile acid test
Test indicators:glycocholic acid (GCA), glycodeoxycholic acid (GDCA), glycochenodeoxycholic acid (GCDCA), glycoursodeoxycholic acid (GUDCA), glycocholic acid (GLCA), taurocholic acid (TCA), taurolithocholic acid (TLCA), taurodeoxycholic acid (TDCA), taurodeoxycholic acid (TCDCA), tauroursodeoxycholic acid (TUDCA), lithocholic acid (LCA), deoxycholic acid (DCA), ursodeoxycholic acid (UDCA), chenodeoxycholic acid (CDCA), cholic acid (CA). Sample request: serum Intended use: for detecting levels of total bile acids and subtypes in vivo
Bile acid
Bile acids are synthesized by hepatocytes and are an essential component of bile, playing a crucial role in the metabolism of fats, intestinal digestion, absorption of lipid compounds, and cholesterol metabolism. Various physiological and pathological factors in the liver and intestinal tract can affect the metabolism and transport of bile acids, resulting in changes in the total bile acid level and bile acid profiles in the body. The determination of serum bile acid plays a critical role in the diagnosis and treatment of liver diseases as serum bile acid profiles vary in different hepatobiliary diseases. The testing of bile acid profile can help improve the differential diagnostic value of bile acid in hepatobiliary diseases. It has important clinical value for the early diagnosis of various acute and chronic hepatitis, as well as for the progress of liver cirrhosis and liver cancer, and the observation of curative effect. In addition, the determination of serum bile acid is also of value in the diagnosis and prognosis of symptomatic enteropathy, intrahepatic cholestasis of pregnancy, congenital biliary diseases, primary liver cancer, liver transplantation, and other diseases.
Indicated for:
Patients with liver and biliary diseases.
People with a history of liver disease infection.
Pregnant women with a history of intrahepatic cholestasis of pregnancy.
Pregnant women with chronic hepatobiliary diseases.
Obese, alcoholic people.